ArticleArchives of gynecology and obstetrics2026
Advanced fetal cardiac monitoring in gestational diabetes mellitus: HbA1c remains the relevant predictor of perinatal outcome under optimal metabolic control.
Article in Archives of gynecology and obstetrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposePerinatal complications can occur in gestational diabetes mellitus (GDM) despite adequate metabolic control and standard diagnostics. Metabolic alterations can cause structural and functional changes in the fetus, especially in the cardiovascular system, by affecting the autonomic nervous system and the cardiac conduction system. Advanced fetal cardiac monitoring may provide detailed insights into these processes and their impact on perinatal outcomes.
methodsIn this exploratory, prospective, single-center cohort study, 172 women with singleton pregnancies between 33 + 0 and 40 + 0 weeks were recruited (56 GDM, 116 controls). Non-invasive fetal ECG (fECG) and computerized cardiotocography (cCTG) assessed the fetal heart rate variability (HRV) and heart time intervals (HTI). Adverse perinatal outcomes (APO) were defined as a composite of the clinically relevant endpoints of operative delivery or emergency cesarean for fetal distress, NICU admission, umbilical cord pH < 7.1, and/or 5-min APGAR < 7. Predictive potential was evaluated using univariate and multivariate regression models.
resultsThe median HbA1c in the GDM group was 5.32%, indicating overall good metabolic control. One hundred forty-five cCTGs and one hundred sixty-three fECGs provided data on HTI and fetal HRV parameters. HTI did not differ between GDM and controls. Although fetal HRV parameters differed, they did not add predictive value for APO. Only maternal metabolic status, as reflected by HbA1c, showed a measurable association with APO (OR 12.83, 95% CI 1.34-122.94).
conclusionIn well-controlled GDM pregnancies, HRV and HTI derived from fECG and cCTG do not enhance risk prediction for APO. Maternal HbA1c remains predictive for the perinatal risk, underscoring the importance of strict metabolic control.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.